中国医药：子公司原料药获得CEP证书

Group 1 - The core point of the article is that China Medical announced the approval of a CEP certificate for Clindamycin Phosphate by its subsidiary Tianfang Pharmaceutical from the European Directorate for the Quality of Medicines (EDQM) [1] Group 2 - The approval of the CEP certificate indicates that the product meets the European Pharmacopoeia standards, which may enhance the company's marketability in Europe [1] - This development could potentially open new avenues for revenue growth for the company in the European pharmaceutical market [1] - The issuance of the CEP certificate reflects the company's commitment to quality and compliance with international standards [1]